Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Veidekke ASA: Key information relating to proposed cash dividend

The board of directors of Veidekke ASA has 8 February 2022 decided to propose payment of cash dividend of NOK 7.00 per share for the financial year 2021. The proposal will be considered at the annual general meeting 11 May 2022. Dividend amount: 7.00 per share Declared currency: Norwegian Krone Last day including rights: 11 May 2022 Ex-date: 12 May 2022 Record date: 13 May 2022 Payment date: 25 May 2022 Date of approval: 11 May 2022 For more information, please contact: Jørgen Wiese Porsmyr, CFO, telephone +47 90 75 90 58 This information is subject to a

Invitation to telephone conference in connection with Green Landscaping Group quarterly report Year-end report 2021

9 February 2022, 07:00 CET Green Landscaping Group publishes its report for the Year-end report 2021 on February 16 at 07:00 CET.CEO Johan Nordström and CFO Carl-Fredrik Meijer will present the report and answer questions during a telephone conference with a web presentation on February 16 at 10:00 CET. Participants dial in: Telephone: SE: +46 8 56642693 UK: +44 3333009264 US: +1 6319131422 PIN: 12740698#Webcast: https://financialhearings.com/event/43430 

Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February

Oslo, Norway, 9 February 2022 - Targovax ASA (OSE: TRVX) will announce its fourth quarter 2021 results on Thursday 17 February 2022. An online presentation by Targovax's management to investors, analysts and the press will take place at 10:00 am CET. The results report and the presentation will be available at www.targovax.com  in the Investors section from 07:00 am CET. Presentation There will be a virtual presentation of the results with a live webcast 17 February at 10.00 am CET. You can join the webcast here 

Elkem ASA – Key information relating to the proposed cash dividend

Oslo, 9 February 2022 Dividend amount:                 NOK 3.00 per shareDeclared currency:               NOKDate of approval:                  27 April 2022Last day including right:       27 April 2022Ex-dividend date:                 28 April 2022Record date:                        29 April 2022Payment date:                      On or about 6 May 2022 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. For further information, please contact:Odd-Geir LyngstadVP Finance & Investor Relations

Elkem ASA - A record fourth quarter concludes Elkem’s best year ever

Oslo, 9 February 2022 In the fourth quarter 2021, Elkem has again delivered new record results. Strong market conditions, combined with an integrated business model and attractive market positions, have provided the basis for Elkem’s best year ever. The board of directors has proposed a dividend of NOK 3.00 per share, representing 41% of the profit for 2021. Elkem’s total operating income for the fourth quarter 2021 was NOK 10,397 million, which was all-time high and up 46% from the corresponding quarter last year. For the full year, Elkem’s operating income reached NOK 33,717 million.

Observe Medical ASA – Commencement of the subscription period for the rights issue

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS STOCK EXCHANGE Reference is made to the previous stock exchange announcements from Observe Medical ASA (the "Company") regarding the rights issue of 25,714,286 new shares in the Company (the "Offer Shares"), raising gross proceeds of

Veidekke ASA: Results Q4 2021 and the year 2021

Veidekke achieved revenues of NOK 10.2 billion in Q4, and a pre-tax profit of NOK 393 million. The group’s order book totalled NOK 38.1 billion at year-end. The profit per share for 2021 was NOK 7.1, and the board is proposing a dividend of NOK 7.0 per share for the financial year 2021.“Veidekke stayed on course in 2021, as confirmed by the fourth-quarter performance. We improved our profitability throughout the year and delivered a better result than in 2020 despite somewhat lower revenues. Infrastructure Norway achieved the greatest improvements both in Q4 and in 2021 as a whole.

Ambea’s year-end report 2021

Sales growth and continued favourable demand for elderly care.CEO comment: During the year, Ambea achieved its best sales ever, despite these unique times for us and society. This result was made possible by the skills and commitment of our employees and the trust we have gained from our clients. In the fourth quarter, demand for elderly care also continued to grow, a trend that lasted for most of the year. Toward the end of the year, the impact of the ongoing pandem­ic once again increased. Despite the high level of community transmission, I can safely say that the incidence of

Highlights of Handelsbanken’s Annual Report

External income and expenses in the operations in Denmark and Finland that are to be divested are recognised as profit/loss from discontinued operations. Unless otherwise stated, descriptions in this highlights report refer to continuing operations. A presentation of the income statement according to previous reporting standards can be found of page 29 of the Fact Book.JANUARY – DECEMBER 2021 January – December 2021- compared with January – December 2020 · Profit for the year increased by 25% to SEK 19,543m (15,588). Profit for the year from continuing operations increased by 29%

ICA Gruppen year-end report 2021

Strong performance during volatile year· Continued strong earnings performance for Apotek Hjärtat and higher market share · Stable earnings for Rimi Baltic in challenging market · ICA Bank launches home mortgages and improves earnings · ICA Sweden – start-up of automated e-commerce warehouse in Stockholm · ICA-handlarnas Förbund and AMF make public acquisition offer to ICA Gruppen's shareholders Fourth quarter 2021 · Consolidated net sales increased by 0.8% to SEK 32,860 million (32,593) · Operating profit excluding items affecting comparability decreased to SEK 1,298

FAZER GROUP JANUARY–DECEMBER 2021: SOLID PERFORMANCE CONTINUED

Financial information in this press release is derived from the Fazer Group’s consolidated financial statements, which are prepared in accordance with the International Financial Reporting Standards (IFRS). The financial information in this release is unaudited. The 2021 financial statements will be published in week 11. The sale of the Fazer Food Services was completed on 31 January 2020. Fazer Food Services is reported as discontinued operations for the one-month period ending 31 January 2020. In 2020, Fazer Food Services’ net sales totalled EUR 50.8 million. Figures in brackets,

Scandinavian Airlines expands at Stockholm Arlanda with new non-stop service to Toronto - strengthens connectivity to North America

Scandinavian Airlines is expanding its route network in North America and will start a new direct route to Toronto from Stockholm in June 2022. The route will be served four times weekly from Stockholm with a brand-new Airbus 321LR aircraft. This summer, it will for the first time be possible to fly non-stop between Sweden and Canada. Scandinavian Airlines (SAS) is expanding at Stockholm Arlanda Airport and strengthening accessibility to North America with a route to Canada's largest city, Toronto. The new service will operate four weekly departures and complements Arlanda's existing

Year-end report 2021 Bactiguard Holding AB

Investments for future sales growth impacted profitabilityFourth quarter (October-December 2021) · Revenues amounted to SEK 46.1 (55.6) million, a decrease of 17%, primarily due to lower license revenue. Adjusted for currency effects revenues decreased by 22%. · EBITDA amounted to SEK -12.1 (4.9) million with an EBITDA margin of -26% (9%). · Operating profit amounted to SEK -23.8 (-6.4) million. · Net loss for the period amounted to SEK -25.4 (-9.4) million. Earnings per share amounted to SEK -0.72 (-0.32). · Cash flow from operating activities amounted to SEK 11.6 (3.9)

Kindred enters new agreement with Kambi and announces long-term in-house Sportsbook plans

Kindred Group has entered into a new agreement with trusted partner Kambi for their B2B sports betting services until the end of 2026. In addition to the agreement, Kindred is extending its current award-winning proprietary Kindred Racing Platform into a full in-house Sportsbook platform, which reflects Kindred’s long-term strategy of greater end-to-end control of its product offering and customer experience.Kindred Group plc (Kindred) has signed a new three-year agreement with long-term partner Kambi Group (Kambi) providing Kindred with operational security of its Sportsbook until the end

Bactiguard presents focused growth strategy and sets new long-term financial targets

Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least 1 billion SEK and annual EBITDA of at least 400 million SEK in 2026."With Bactiguard's unique technology for infection prevention, scalable business model, broader product portfolio and focused market coverage, our target is to reach annual sales of at least 1 billion SEK, with an EBITDA of at least 400 MSEK in 2026. We will focus on six therapeutic areas and prioritized countries and grow sales

Nordea Bank Abp: Repurchase of own shares on 08.02.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares08.02.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 08.02.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 368,270 10.69 3,936,045.19XHEL 241,712 10.71 2,587,889.53CEUX 329,747 10.70 3,527,683.00AQEU 30,718 10.69

Nordea announces ECB approval of share buy-back application

Nordea Bank AbpStock exchange release – Other information disclosed according to the rules of the Exchange8 February 2022 at 22.00 EET Nordea Bank Abp has received approval from the European Central Bank (ECB) for further share buy-backs of EUR 1.0bn. A follow-on buy-back programme is expected to be initiated once the inaugural buy-back programme has ended. Nordea’s application to further repurchase up to EUR 1.0bn of its own shares was approved by the ECB on 8 February 2022. The inaugural share buy-back programme, which started on 22 October 2021, is progressing and expected to

YA Holding publishes bond prospectus and applies for admission to trading of social sustainability-linked bonds on Nasdaq Stockholm

On 17 December 2021, YA Holding AB (publ) (“YA Holding”) successfully issued senior secured social sustainability-linked bonds in an initial amount of SEK 480 million, under a total framework of SEK 650 million (the “Bonds”). The Bonds have a tenor of three years and a floating interest rate of STIBOR three months plus 875 bps. Pursuant to the terms and conditions for the Bonds, YA Holding has undertaken to apply for admission to trading of the Bonds on the sustainable bond list of Nasdaq Stockholm. For this purpose, the company has prepared a listing prospectus, which today has been

Bactiguard will publish its year-end report for 2021 tonight at 23.00

Following the announcement of the expanded partnership with Zimmer Biomet, Bactiguard has decided to publish the year-end report for 2021 tonight at 23.00 CET, instead of on Thursday February 10, as earlier announced.An audiocasted presentation will take place on Wednesday February 9 at 15.00 CET. Bactiguard's CEO Anders Göransson and CFO Gabriella Björknert Caracciolo will present the year-end report, comment on the expanded global partnership and answer questions. The presentation will be held in English. To participate in the audiocast, please use this link:www.bactiguard.com/Q4-

Odfjell SE 4Q21: Encouraging finish to a difficult year

Odfjell SE today reported its results for the fourth quarter of 2021 and preliminary results for the full year 2021. The report shows an encouraging finish to a difficult year driven by improving Chemical tanker markets in the West and continued strong markets in the East. Highlights for 4Q21: · Timecharter earnings in Odfjell Tankers of USD 136 million, up USD 11 million compared to USD 125 million in 3Q21 · Net result contribution from Odfjell Terminals of USD 3 million, compared to USD 1 million in 3Q21 · EBIT of USD 35 million, up USD 42 million compared to USD -7 million

Bactiguard and Zimmer Biomet expand global license partnership

Bactiguard and Zimmer Biomet have today agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments.The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), sports medicine, craniomaxillofacial and thoracic applications. It includes license and development fees of USD 1.5 million payable in 2022, additional contingent milestone payments of USD 7.5 million based on U.S. regulatory clearance for different product categories, and royalties on net sales following commercialization.   “Our

Enviro receives a pyrolysis oil order worth MSEK 2 from a subsidiary of a leading US oil company

Scandinavian Enviro Systems has received a recovered pyrolysis oil order worth MSEK 2 from the subsidiary of a leading US oil company. The oil will be used for production tests at a European oil refinery owned by the oil company. Completion of the transaction is conditional upon Enviro’s recovered oil gaining a registration in accordance with the EU chemicals regulation, REACH. The company expects to obtain a REACH registration for the oil as an intermediate during the second quarter of 2022.The oil company is one of the five largest oil companies in the US and the oil will be used to

Basalt, through Ride BidCo AB, announces final outcome in the offer to the shareholders of Nobina AB (publ)

This announcement is not an offer, whether directly or indirectly, in Australia, Canada, Hong Kong, Japan, New Zealand, Singapore or South Africa or in any other jurisdiction where such offer would be prohibited by applicable law pursuant to legislation, restrictions and regulations in the relevant jurisdiction. Shareholders not resident in Sweden who wish to accept the Offer (as defined below) must make inquiries concerning applicable legislation and possible tax consequences. Shareholders should refer to the offer restrictions included in the section titled "Important notice" at the end of

Assume the Seat of Power in Crusader Kings III: Royal Court

First Major Expansion for Medieval Grand Strategy Game Available NowSTOCKHOLM - 08 February 2022 - Your court is the heart of your kingdom, and now, in Crusader Kings III: Royal Court, you will be able to engage in vital affairs of state in a new game area to awe visitors with your splendor and display marvelous items and artifacts. The first major expansion for Paradox’s award-winning grand strategy role-playing game is now available. Decorate your court with works of art created by master craftspeople or with rare artifacts captured or inherited across the generations. Hear the pleas

There are no items matching the current filter
There are no more items matching the current filter
Back to top